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Abstract
Background: Skeletal muscle displays a marked accumulation of denervated myofibers at advanced age, which
coincides with an acceleration of muscle atrophy.
Methods: In this study, we evaluated the hypothesis that the accumulation of denervated myofibers in advanced
age is due to failed reinnervation by examining muscle from young adult (YA) and very old (VO) rats and from a
murine model of sporadic denervation secondary to neurotrypsin over-expression (Sarco mouse).
Results: Both aging rat muscle and Sarco mouse muscle exhibited marked fiber-type grouping, consistent with
repeating cycles of denervation and reinnervation, yet in VO muscle, rapsyn at the endplate increased and was associated
with only a 10 % decline in acetylcholine receptor (AChR) intensity, whereas in Sarco mice, there was a decline in rapsyn
and a 25 % decrease in AChR intensity. Transcripts of muscle-specific kinase (21-fold), acetylcholine receptor subunits α
(68-fold), ε (threefold) and γ (47-fold), neural cell adhesion molecule (66-fold), and runt-related transcription factor 1 (33-fold)
were upregulated in VO muscle of the rat, consistent with the marked persistent denervation evidenced by a large
proportion of very small fibers (>20 %). In the Sarco mice, there were much smaller increases in denervation transcripts
(0–3.5-fold) and accumulation of very small fibers (2–6 %) compared to the VO rat, suggesting a reduced capacity for
reinnervation in aging muscle. Despite the marked persistent denervation in the VO rat muscle, transcripts of
neurotrophins involved in promoting axonal sprouting following denervation exhibited no increase, and several miRNAs
predicted to suppress neurotrophins were elevated in VO rat.
Conclusions: Our results support the hypothesis that the accumulation of denervated fibers with aging is due to failed
reinnervation and that this may be affected by a limited neurotrophin response that mediates axonal sprouting following
denervation.
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Background
Skeletal muscle undergoes repeating cycles of denervation
and reinnervation for much of adult life [1]. However, in
very advanced age, when muscle atrophy becomes severe
and has clinical impact in terms of impairing mobility [2],
there is a marked accumulation of persistently denervated
muscle fibers [3, 4]. Notably, we have shown in very old
(VO) rat muscle that denervated myofibers are on average
35–50 % smaller than innervated fibers and innervated fi-
bers of VO muscle are only 7 % smaller than in young
adult [3]. The significance of this is that denervation is the
primary cause of atrophy in the period of the lifespan
when the clinical impact of aging muscle is most relevant.
As an accumulation of persistently denervated fibers
marks the acceleration of atrophy in both slow and fast
twitch muscles with aging [5], understanding the mecha-
nisms contributing to their accumulation is essential to
provide effective targets for combating age-related muscle
atrophy.
Although there have been a number of recent studies
examining the mechanisms that may contribute to
destabilization of the aging neuromuscular junction (NMJ)
and subsequently lead to denervation of muscle endplates
[6–8], there is scant information about the potential mecha-
nisms contributing to impaired reinnervation of denervated
fibers in very advanced age. Importantly, the progressive
increase in fiber type grouping seen with increasing age [9]
is clear evidence that following a sporadic denervation event,
such fibers are usually successfully reinnervated for much of
the lifespan. For this reason, a likely cause for the accumula-
tion of persistently denervated fibers in very advanced age is
a failure of reinnervation. In this context, previous studies
have noted an impaired reinnervation response following
acute nerve injury in aged animals that is due to impaired
axonal regrowth [10, 11]. Despite this evidence, no prior
studies have considered whether this impaired capacity for
axonal regrowth (identified following acute nerve injury in
aged animals) might also contribute to the accumulation of
persistently denervated muscle fibers following denervation
events that are part of the normal process of aging.
In addressing factors that might cause a compromised
reinnervation response with aging, it is relevant to note that
following surgical denervation in healthy young animals,
there is a robust increase in neurotrophins, including
brain-derived neurotrophic factor (BDNF) [12]. Further-
more, forced over-expression of the neurotrophins BDNF,
glial-derived neurotrophic factor (GDNF) and nerve growth
factor (NGF) in muscle facilitate axonal sprouting and rein-
nervation following surgical denervation [13]. Similarly, the
exercise-induced enhancement of reinnervation following
nerve crush injury is dependent upon muscle BDNF signal-
ing [14]. As such, examination of neurotrophins involved in
reinnervation and microRNAs (miRNAs) predicted to
suppress neurotrophins could provide insights to the
potential cause of failed reinnervation in very advanced age
or at the least identify whether this pathway might repre-
sent a therapeutic target.
To help address these issues, we examined muscle
morphology (fiber type and size distribution, fiber type
grouping) and denervation-related transcripts (e.g., muscle
specific kinase [MuSK], AChR subunits, cytoplasmic
phospholipase A2 [cPLA2], neural cell adhesion molecule
[NCAM], and runt-related transcription factor 1 [RUNX1])
in vastus lateralis (VL) muscle from young adult (YA;
8 months old) and very old (VO; 35 months old) male
Fisher 344 × Brown Norway F1-hybrid (F344BN) rats and
compared this to the same measures made in soleus and
gastrocnemius muscles from male wild-type (WT) and
neurotrypsin-over-expressing mice (Sarco mouse; a model
of sporadic denervation). A key element of the study design
is that the age of the Sarco mice (8 months of age) allows
us to evaluate the capacity for reinnervation of young adult
muscle subjected to sporadic denervation. We hypothesized
that both VO rats and Sarco mice would exhibit marked
fiber type grouping (indicating repeating cycles of denerv-
ation and reinnervation in both models) but compared to
Sarco mice, VO rat muscle would exhibit a greater accumu-
lation of small fibers indicative of persistent sporadic de-
nervation and a commensurately greater expression of
denervation-related transcripts. As both aging [9] and
neurotrypsin over-expression [7] cause repeating cycles of
denervation and reinnervation, a greater accumulation of
sporadically denervated muscle fibers and up-regulation of
denervation-related transcripts would implicate failed rein-
nervation as a major contributor to the accumulation of
persistently denervated muscle fibers in advanced age. To
provide insights to potential mechanisms of failed reinner-
vation in VO muscle, we also examined neurotrophin tran-
scripts and miRNAs predicted to blunt neurotrophin levels.
Results
Fiber type proportions and fiber type grouping in aged
rat and Sarco mice
Figure 1a shows representative images of the rat vastus
lateralis and Sarco mouse soleus muscle cross-sections la-
beled using primary antibodies against myosin heavy chain
(MHC) isoforms to identify fiber type and laminin to dis-
tinguish fiber borders. Proportions of pure fibers (types I,
IIa, IIb, and IIx) were lower in the VO rat muscle com-
pared to YA and lower in Sarco mice than wild-type mice.
This decline in pure fibers was accounted for by an in-
crease in abundance of fibers co-expressing two or more
MHCs (MHC co-expressing fibers) in the VO rat and
Sarco mice (Fig. 1b), a phenotype that we have shown pre-
viously to be largely secondary to denervation in the VO
rat muscle [3]. To obtain an index of the occurrence of
denervation-reinnervation events, we examined the abun-
dance of fibers totally enclosed by fibers of the same type
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(fiber type grouping) in rat and mouse muscle. This
analysis revealed that there was a large increase in fiber
type grouping in both VO rat and Sarco mouse muscle
(Fig. 1c).
MuSK-rapsyn at the neuromuscular junction
To evaluate changes in one of the primary signaling axes
for regulating the integrity of the post-synaptic AChR
plaque, we examined phospho-MuSK, rapsyn, and AChR
intensity levels in the endplate region of the muscle fiber
in both the aging and Sarco mice (Fig. 2). Interestingly,
whereas immunofluorescent images show relatively
preserved phospho-MuSK and semi-quantitative analysis
in muscle cross-sections revealed an increase in rapsyn
and only a small (10 %) decline in AChR intensity in VO
rat muscle, phospho-MuSK appeared considerably re-
duced in Sarco Soleus muscle and this was accompanied
by a decline in rapsyn and relatively large (25 %) decline
in AChR intensity.
Fiber size in aged rat and Sarco mice
To gain insight into the frequency of failed reinnervation
events in the VO rat, we examined the abundance of















































































































































Fig. 1 Muscle fiber type and type grouping. a Transverse muscle sections from rat vastus lateralis (VL) and mouse soleus muscle. Young adult
(YA) vs very old (VO) rat VL muscle and wild-type (WT) vs Sarco mouse soleus were labeled with laminin to visualize the basal lamina and antibodies
against the myosin heavy chains to visualize fiber types. Scale bars= 100 μm. Type I (blue), type IIa (red), type IIx (green), type IIb (black [no staining])
were labeled. b Fiber type proportions in YA vs VO rat and WT vs Sarco mouse. c Fiber type grouping in YA vs VO rat and WT vs Sarco mouse. In b
and c, the data shown are means with standard error
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represent a population of muscle fibers shown by our
group in VO rat gastrocnemius muscle to exhibit a high
association with positive labeling for a marker of denerv-
ation (>90 % of these fibers are positive for the sodium
channel isoform, Nav1.5) and to represent <1 % of fibers
from young adult muscle [3]. We then compared this to
a corresponding fiber size in Sarco mice (650 μm2 in
gastrocnemius, 575 μm2 in soleus), based upon these
representing a similar percentile of fiber size in the WT
mice as in the YA rat. Interestingly, whereas VO rat
exhibited >20 % of these very small fibers, Sarco mice
exhibited approximately 2–6 % of these very small fibers
(higher in soleus than gastrocnemius) (Fig. 3a). Taken in
the context of the high frequency of denervation-
reinnervation events evidenced by the large increase in
fiber type grouping in both VO rat VL and Sarco mouse
soleus muscle noted above (Fig. 1c), our analysis of very
small fiber abundance reveals a marked impairment in
reinnervation in VO rat muscle. On the other hand, a
degree of compensatory hypertrophy was visually evi-
dent in photomicrographs of Sarco soleus muscle
(Fig. 1a), consistent with a previous report [7].
Transcriptional profile of denervation in aged rat and
Sarco mice
The expression of denervation-related transcripts was dra-
matically increased in VL muscle of VO rat samples when
compared to YA, and these increases were markedly
greater than seen in Sarco mouse soleus or gastrocnemius
muscles (Fig. 3b). Specifically, transcript levels of MuSK, a
key signaling molecule involved in regulation of AChR
clustering at the neuromuscular junction [15, 16], in-
creased 21-fold in VO muscle (20–50 % change in Sarco
mouse muscles). Similarly, transcript levels of the AChR
subunit α (68-fold in VO vs YA) and γ (47-fold in VO vs
YA) increased to a much greater degree in VO rat muscle
than in Sarco mouse soleus muscle where AChR α had a
borderline significant increase and AChRγ modestly in-
creased (threefold) (no change in gastrocnemius muscle)
vs wild-type mice. Interestingly, whereas AChR ε in-
creased approximately threefold in VO rat VL muscle, it
declined by nearly 60 % in Sarco soleus muscle. Transcript
levels of NCAM (50-fold higher in VO vs YA), which en-
codes a protein that increases in aging muscle [17] and is
involved in restoration of nerve contact to the muscle
[18], and RUNX1 (40-fold higher in VO vs YA), which en-
codes a protein that also increases in aging muscle [19]
and counters muscle atrophy [20], were markedly elevated
in VO rat muscle but not in Sarco mouse soleus or gastro-
cnemius muscle. Transcript levels of cPLA2, an enzyme
catalyzing release of mitochondrial lipids as fatty acid hy-
droperoxides following denervation [21], increased in VO
rat VL muscle and in Sarco mouse Soleus muscle (both
approximately twofold relative to their respective con-
trols). Collectively, these results identify a markedly
greater denervation-related transcriptional profile in VO
rat muscle than the Sarco mouse, despite both models be-






























































YA VO WT Sarco
Fig. 2 Protein analyses at the muscle endplate region. a Representative images of muscle endplates from YA vs VO (VL muscle) and WT vs Sarco
(gastrocnemius muscle) labeled with primary antibodies against phospho-MuSK (scale bars = 10 μm). b Semi-quantitative analysis of protein intensities
at the muscle endplate for rapsyn and AChRs in YA (n = 154–158 endplates) vs VO (n = 304–311 endplates) (VL muscle) and WT (n = 185 endplates) vs
Sarco (n = 287–296 endplates) (gastrocnemius muscle). Values are normalized as a fold change of YA or WT, respectively. *P < 0.05 vs corresponding
group within the same species
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Transcriptional profile of neurotrophins and related
receptors in aged muscle
The gene expression of neurotrophins (Fig. 4a left
panel), including those implicated in promoting axonal
growth following nerve injury [12, 13], were not signifi-
cantly elevated in VO muscle, despite the marked accu-
mulation of very small muscle fibers and large increases
in expression of denervation-related transcripts. This
was also the case in both muscles examined in Sarco
mice (Fig. 4b, c left panels), although the denervation
stress here is clearly less than with aging and there is
likely less requirement for axonal sprouting due to the
exclusively post-synaptic nature of the NMJ instability in
this model. When considering transcripts for the
neurotrophin receptors (Fig. 4b), only neurotrophic tyro-
sine kinase receptor type 3 (NTRK3; encodes the NT3 re-
ceptor) and ciliary neurotrophic factor receptor (CNTFR;
encodes the CNTF receptor) were increased in rat VO
muscle. The other neurotrophin receptors, p75NTR (en-
coding the low affinity nerve growth factor receptor for
several neurotrophins), neurotrophic tyrosine kinase recep-
tor type 1 (NTRK1; encoding the high-affinity receptor for
NGF), neurotrophic tyrosine kinase receptor type 2
(NTRK2; encoding the high-affinity receptor for BDNF),
and GDNF family receptor alpha-1 (GFRA1; encoding the
GDNF receptor) exhibited no change in rat VO muscle
compared to YA muscle (Fig. 3a, c). Similar to aging











































































































































































































Fig. 3 Morphological and transcriptional markers of denervation. a Abundance of very small fibers in YA vs VO rat vastus lateralis muscle, WT vs Sarco
mouse gastrocnemius muscle, and WT vs Sarco mouse soleus muscle. b qPCR analysis of denervation markers: MuSK, AChRa, AChRe, AChRg, cPLA2,
NCAM, and RUNX1 in YA (n = 8) vs VO (n = 10) rat vastus lateralis muscle and WT (n = 8) vs Sarco mouse (n = 6) gastrocnemius and soleus muscle.
TBP was used as endogenous control. Data are shown as means with standard error. T tests were performed. *P < 0.05 was considered as
statistically significant
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receptor transcripts in the Sarco mice, with only NTRK1
exhibiting a small decline in expression in Sarco mouse
gastrocnemius muscle Fig. 4b, c left panels. Although this
analysis does not reveal a decline in neurotrophin signal-
ing in the VO muscle, taken in the context of the large in-
crease in very small fibers and denervation-related
transcripts, a reasonable conclusion is that the neurotro-
phin response is insufficient to facilitate successful
reinnervation.
Age-related changes in miRNAs predicted to suppress
neurotrophins in aged muscle
Analysis of the BDNF 3′ untranslated region (UTR)
using TargetScan (www.targetscan.org) revealed several
target sites for BDNF: miR-206-3p, miR-10a-5p, miR-1b,
miR-195-5p, and miR-497-5p that were conserved in
humans. Both miR-206-3p and miR-1b have the same
seed sequence (ACAUUCC). In VO rat muscle, miR-206-
3p, miR-195-5p, and miR-497-5p were increased signifi-
cantly. In contrast, miR-1b decreased and there was no
change observed in miR-10a-5p (Fig. 5a). Similarly, Tar-
getScan analysis identified the following miRNAs that are
conserved in humans and are predicted to influence the
NT3 gene: miR-21-5p, miR-222-3p, and miR-221-3p. Both
miR-222-3p and miR-221-3p share the same seed se-
quence (AUGUAGCA). In VO rat muscle, miR-21-5p and
miR-221-3p were increased significantly (Fig. 5b). Finally,
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Fig. 4 Neurotrophin and receptor transcript analysis. qPCR analysis of the neurotrophins: BDNF, NGF, NT3, NT4/5, GDNF, CNTF and neurotrophin
receptors: p75, NTRK1, NTRK2, NTRK3, GFRA1, and CNTFR in YA (n = 8) vs VO (n = 10) rat VL (a), Sarco gastroc (b), and Sarco soleus (c) muscles. TBP was
used as endogenous control. Data are shown as means with standard error. T tests were performed. *P < 0.05 was considered as statistically significant
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conserved in humans as likely to influence NGF transcript
levels: let-7b-5p and miR-98-5p and these miRNAs share
a common seed sequence (CUACCUCA). Both let-7b-5p
and miR-98-5p were increased significantly in VO rat
muscle (Fig. 5c). Thus, collectively, seven out of the ten
miRNAs identified as likely candidates for suppressing
neurotrophin expression were elevated in aging muscle.
Of these, only miR-98-5p exhibited an increase in Sarco
mouse gastrocnemius muscle (this analysis was not pos-
sible in soleus due to limited tissue).
Discussion
There is a need for identification of viable therapeutic tar-
gets to treat aging muscle in advanced age where the
clinical impact of muscle atrophy becomes meaningful. A
key step in this endeavor is a clear understanding of the
processes that lead to muscle atrophy in advanced age. To
this end, the purpose of this study was to evaluate the hy-
pothesis that the accumulation of persistently denervated
muscle fibers in advanced age is due to failed reinnerva-
tion by comparing changes with aging to changes seen in
a mouse model of sporadic denervation, the Sarco mouse.
Our results show that VO rat VL muscle is character-
ized by marked accumulation of very small fibers and
MHC co-expression, two hallmark features of sporadic
denervation in aging muscle [3]. Although there are
many reasons fiber atrophy could occur, its sporadic na-



















































































































































































































































Fig. 5 MicroRNA analysis. MicroRNAs predicted to influence neurotrophins: a BDNF (miR-206-3p, miR-10a-5p, miR-1b, miR-195-5p and miR-497-5p), b NT3
(miR-21-5p, miR-222-3p and miR-221-3p), and c NGF (let-7b-5p and miR-98-5p) were quantified by qPCR analysis in YA (n= 8) vs VO (n=10) rat vastus lateralis
muscle and WT (n= 8) vs Sarco (n= 7) gastrocnemius muscle. miR-191a-5p was used as endogenous control. Data are shown as means with standard error.
T tests were performed. *P< 0.05 was considered as statistically significant
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normal sized fibers) in VO muscle is also seen in neuro-
muscular diseases that exhibit denervation, such as
amyotrophic lateral sclerosis and spinal muscular atro-
phy [22]. Further, to this point, although MHC co-
expression can also occur in the context of sedentary
lifestyle with aging and is reduced in response to exer-
cise training [23], a distinguishing feature in VO rat
muscle is that MHC co-expression most often co-
localizes with other features of denervation, including
small and angular fiber size and Nav1.5 expression [3].
Furthermore, VO rat muscle exhibited marked fiber type
grouping (indicative of many repeating cycles of denerv-
ation and reinnervation [9]) and large induction of tran-
scripts known to respond to denervation. In contrast,
despite significant fiber type grouping in Sarco mouse
muscle and a high abundance of MHC co-expressing fi-
bers (suggesting that, similar to normal aging, Sarco
mice also undergo many repeating cycles of denervation
and reinnervation), the abundance of small fibers and in-
duction of denervation-related transcripts compared to
WT mice was much smaller than seen with aging. This
analysis suggests a robust reinnervation response in
young muscle (evidenced by the Sarco mouse) and in
turn a poor reinnervation response of aging muscle. In
identifying a possible mechanism for failed reinnerva-
tion, our analysis suggests that an insufficient neurotro-
phin response in aging muscle may contribute to the
persistence of denervated muscle fibers and that this may
be attributable to increases in miRNAs that suppress neu-
rotrophin expression in aging muscle. The translational
significance of these observations is that they suggest that
up-regulation of neurotrophin signaling could be an ef-
fective therapeutic approach for attenuating muscle atro-
phy by facilitating reinnervation in advanced age where
muscle impact is clinically meaningful.
The evolving causes of atrophy in aging muscle
Whereas at ages ≤75 years old muscle fibers atrophy
relatively uniformly [24], in more advanced ages where
the severity of muscle atrophy is more likely to have
clinical impact [2], the muscle morphology is punctuated
by a marked accumulation of small angular fibers that
are interspersed amongst relatively normal-looking
muscle fibers [4]. Identification of processes that can
lead to sporadic fiber atrophy in aging muscle is thus
key to understanding the causes of muscle atrophy in
advanced age. Although segmental accumulation of
mitochondrial defects has been considered a cause of
muscle fiber atrophy with aging [25], the fraction of
fibers harboring mitochondrial defects that exhibit atro-
phy is very small (5 %) [5, 26] and thus unlikely to repre-
sent a key target. On the other hand, we have shown
that there is a marked accumulation of small angular fi-
bers that coincides with the acceleration of muscle
atrophy in both slow and fast twitch muscles in ad-
vanced aging [5] and that >90 % of these fibers label
positively for a sodium channel isoform, Nav1.5 [3], that
is upregulated in response to denervation [27]. It is for
this reason that we have focused the current study on
identifying mechanisms that could account for the accu-
mulation of persistently denervated muscle fibers in
aging muscle.
Sarco mouse as a model of sporadic denervation
In our studies, we used a genetic model of sporadic de-
nervation, the Sarco mouse [28]. This model was engi-
neered to over-express the endogenous protease,
neurotrypsin, in neurons which in turn causes increased
agrin cleavage at the neuromuscular junction and re-
duces activation of MuSK [7]. The result is less recruit-
ment of rapsyn to the subsynaptic microdomain, a
resulting loss of cytoskeletal tethering of the post-
junctional AChRs, and thus, an increased susceptibility
to sporadic denervation. Although we present data from
both gastrocnemius and soleus muscles, our analysis
shows that for the parameters examined, the changes are
generally greater in the soleus muscle. For example,
there was a greater increase in fraction of very small
muscle fibers and larger changes in denervation-related
transcripts in the relatively slow twitch postural soleus
muscle compared to the largely fast twitch gastrocne-
mius muscle in the Sarco mice. Thus, whilst fiber type
and muscle recruitment are clearly different between rat
VO and mouse Soleus muscles, the Sarco mouse soleus
is more affected and might on this basis provide a better
indicator of the degree to which reinnervation is com-
promised with aging.
Consistent with prior studies using this model [7, 28], the
Sarco mice exhibited smaller muscle mass and a pro-
nounced fiber type shift punctuated by a large accumulation
of MHC co-expressing fibers. Furthermore, phospho-MuSK
levels at the NMJ were seen to decrease (Fig. 2a), as would
be expected in response to reduced agrin activation of
MuSK [7], and this was accompanied by a reduced rapsyn
and AChR intensity in the post-synaptic endplate region. In
addition, we observed marked fiber type grouping (only ex-
amined in soleus muscle) and moderate increases in some
denervation-related transcripts (MuSK in both muscles, and
AChRγ and cPLA2 in soleus muscle). We also noted a nearly
60 % decrease in AChR ε subunit in Sarco soleus muscle,
which contrasts with the increase in AChR ε that was seen
in VO rat muscle. In this respect, previous studies have
shown that following denervation AChR ε expression under-
goes a multiphasic response: (i) an initial decrease in the first
10 day post-denervation [29]; (ii) a sharp increase observed
approximately 4 weeks following denervation; (iii) a decline
over the next 4 weeks; and (iv) a gradual secondary increase
when denervation persists beyond 2 months [30, 31]. Thus,
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the differences between the VO rat and Sarco mouse likely
reflect differences in the duration of denervation, with the
higher AChR ε in VO rat reflecting more prolonged denerv-
ation and the reduced AChR ε in Sarco mouse reflecting the
acute denervation response.
A caveat to comparing the Sarco mouse to aging
muscle concerns the frequency of sporadic denervation
events. The large increase in frequency of enclosed fibers
(Fig. 1c) shows both are exposed to many recurring cy-
cles of denervation and reinnervation. Accepting that it
is not possible to obtain a quantitative comparison of
the exact frequency of denervation (e.g., on a daily or
weekly basis) events in the two models, the value of the
Sarco mouse herein is that it provides an indicator of
the normal capacity for reinnervation of young adult
muscle in the context of significant neuromuscular junc-
tion instability, and as such, suggests a compromised re-
innervation capacity of VO muscle. On the other hand,
we cannot rule out that the aging muscle might undergo
a higher frequency of denervation events, which is itself
the problem (rather than failed reinnervation per se). As
noted above, however, the AChR ε response in the VO
rat is more consistent with prolonged persistent denerv-
ation rather than a greater burden of denervation per se.
Causes of denervation and failed reinnervation in aging
muscle
Skeletal muscle undergoes repeating cycles of denerv-
ation and reinnervation throughout much of the adult
life, resulting in remodeling of the aging motor unit that
in turn causes significant grouping of fibers of the same
type [9]. The causes of individual denervation events
with aging may involve gradual changes in the signaling
pathways necessary for NMJ maintenance and/or a sud-
den change such as muscle injury or motor neuron loss
[32]. In our aging rat model, we have previously shown
in the same animals studied here that there is a 27 %
loss of motor neuron cell bodies in the spinal cord [3],
indicating a significant pre-synaptic element causing de-
nervation in VO rat muscle. This is in contrast to the
Sarco mouse where the defect is downstream of the
motor neuron and where motor neuron number in the
spinal cord is maintained [7]. Thus, although both
models exhibit denervation, the causes may be quite dif-
ferent. This notion is supported by the fact that in our
study, phospho-MuSK was maintained in aging muscle
(decreased in Sarco mouse), rapsyn was increased (re-
duced in Sarco mouse), and this resulted in only a small
loss of AChR intensity in the post-synaptic endplate
region of aging muscle (much larger reduction in AChR
intensity in Sarco mouse).
Consistent with other studies that have examined tran-
scriptional responses in aging muscle [19, 33], in VO rat
muscle, we observed increases in several transcripts that
change with denervation. The large magnitude of these
changes underscores the very significant denervation
stress present in the VO muscle, and this contrasts
markedly with the much smaller changes seen in Sarco
mouse muscles. Notably, previous studies have shown
that the neurotrophins BDNF, NGF, and GDNF are
important to promote motor axon sprouting and
recovery of innervation following surgical denervation
[12, 13, 34]. Furthermore, interventions that increase sig-
naling through BDNF and/or its receptor TrkB markedly
improve recovery of diaphragm function following cer-
vical spinal cord injury [35–37]. Yet, we observed largely
non-significant increases in the neurotrophin and neuro-
trophin receptor transcripts in VO rat muscle which
could indicate a failed response to the marked presence
of sporadically denervated fibers in aging muscle. This
notion is consistent with previous studies showing im-
paired BNDF signaling in aging limb muscle [38] and
diaphragm [39]. In contrast to aging muscle, the fact
that motor neurons are spared in neurotrypsin-over-
expressing mice [7] would obligate less extensive axonal
sprouting to facilitate reinnervation in this context.
Thus, the negligible changes in neurotrophins and their
receptors in Sarco mouse muscles are not unexpected. It
follows that a significant limitation to our interpretation
of the neurotrophin response in VO muscle is that we do
not have a model to indicate the “normal” adult neurotro-
phin response to sporadic motor neuron loss. Such infor-
mation could be obtained from either experimental
models involving a less severe form of denervation involv-
ing partial nerve crush or a genetic model involving motor
neuron loss. Regardless of this limitation, on the basis of
the aforementioned evidence showing the importance of
neurotrophins in promoting axonal sprouting and reinner-
vation following experimental denervation, therapeutically
targeting the neurotrophins in advanced age is worthy of
evaluation.
Potential involvement of miRNA-induced suppression of
neurotrophins
There has been remarkable progress in recent years in
identification of miRNAs, opening up new avenues of re-
search into mechanisms of disease [40, 41], as well as
mechanisms that can contribute to muscle impairment
in various disorders [42, 43]. Although it is well estab-
lished that miRNAs can suppress gene expression by
pairing with target mRNAs to direct their degradation
or influence the mRNA translation capacity [44], very
few studies have examined miRNAs in the context of
aging muscle [45, 46], and none specifically in the con-
text of the causes of persistent denervation. Thus, in
seeking mechanisms that might account for a blunted
neurotrophin response to denervation in aging muscle,
we first used TargetScan to identify potential miRNAs
Aare et al. Skeletal Muscle  (2016) 6:29 Page 9 of 13
that could suppress neurotrophins. This analysis identi-
fied 10 miRNAs that are conserved in humans and
which target three neurotrophins involved in promoting
axonal sprouting following nerve injury. For BDNF, our
analysis identified increases in miR-206-3p, miR-195-5p,
and miR-497-5p in VO rat muscle. Similarly, for NT3,
our analysis identified significant increases in miR-21-5p
and miR-221-3P in VO rat muscle. Finally, for NGF, our
analysis revealed an increase in both let-7b-5p and miR-
98-5p in VO rat muscle. Of these, miR-206 has previ-
ously been shown to increase in aging mouse muscle
[46], consistent with our analysis in VO rat muscle.
Similarly, miR-195 (predicted to target BDNF), and let-
7b and miR-98 (both predicted to target NGF) have been
shown previously in human muscle to increase with aging
[45], consistent with our analysis in VO rat muscle. To
our knowledge, none of the other miRNAs that we identi-
fied as potentially suppressing neurotrophins have been
examined previously in the context of aging muscle.
In contrast to the aforementioned studies in aging
muscle, most of the miRNAs studied herein have been
examined in the context of experimental denervation,
including miR-206 (increases after reinnervation), miR-
10a-5p (increases four- to seven-fold with denervation),
miR-1 (increases up to 10-fold following denervation
and remains elevated after reinnervation), miR-195 (in-
creases up to 10-fold with denervation), miR-21 (in-
creases with denervation), miR-221 (no consistent
change), miR-222 (no consistent change), and miR-98
(increases up to 10-fold with denervation) [43, 47, 48].
Note that we also saw an increase in miR-98-5p in Sarco
mouse muscle, which likely reflects a normal response
to denervation. Thus, the normal response to experi-
mental denervation, and in the current study, a model of
NMJ instability (Sarco mouse), is often an increase in
miRNAs that are predicted to target neurotrophin genes.
The miRNAs that exhibited a different response in VO
rat muscle from what is seen with experimental denerv-
ation are miR-1, which in experimental denervation in-
creases [48] but in VO rat muscle was observed to
decline, and miR-221, which does not change with de-
nervation [47] but was observed to increase in VO rat
muscle. Since miRNAs frequently target more than a
single mRNA species, a simple interpretation of the bio-
logical significance of the changes observed is challen-
ging. Thus, whether miRNA sponges [41] or other
approaches to silencing miRNA signaling would be ef-
fective in promoting reinnervation in aging muscle by
amplifying the neurotrophin response, will need experi-
mental validation.
Conclusions
The purpose of our study was to evaluate whether the
marked accumulation of persistent denervated fibers in
muscle at advanced age is due to failed reinnervation. Con-
sistent with our hypothesis, VO rat muscle exhibited a
much greater accumulation of very small muscle fibers and
denervation-related transcripts than Sarco mouse muscle,
even though both models evidenced marked fiber type
grouping indicative of recurring cycles of denervation and
reinnervation. In spite of this significant denervation stimu-
lus in VO rat muscle, the neurotrophin pathways known to
drive axonal sprouting following acute nerve injury exhib-
ited a minimal induction (with most changes not reaching
statistical significance). We conclude that failed
reinnervation is an important mechanism driving the accel-
eration of muscle atrophy in advanced age and that thera-
peutically targeting the neurotrophin response to stimulate
axonal sprouting would be worthy of exploration.
Methods
Experimental procedures
Animals and tissue collection
We studied 8-month-old (young adult; YA; n = 8) and
35–36-month-old (very old; VO; n = 10) male Fischer
344 X Brown Norway F1-hybrid (F344BN) rats obtained
from the National Institute on Aging (USA) colony.
Upon arrival at the University of Calgary Biological
Sciences vivarium, the animals were housed individually
in cages fitted with filter bonnets and maintained in a
12:12-h light/dark cycle at 23 °C for at least 48 h before
experiments. On the day of experiments, the animals
were anesthetized with 55–65 mg kg−1 of sodium pento-
barbital and the left vastus lateralis muscle was removed,
trimmed of adipose and connective tissue, and weighed.
A slice through the entire midbelly of the vastus lateralis
muscle was mounted transversely on pieces of cork using
optimal cutting temperature compound and frozen in iso-
pentane pre-cooled in liquid nitrogen before being stored at
−80 °C. Remaining muscle portions were frozen in liquid ni-
trogen for RNA and microRNA measurements and stored
at −80 °C. All procedures with F344BN rats were conducted
with approval from the Animal Care Committee at the
University of Calgary (ID B109R-11).
Neurotrypsin over-expressing C57BL/6 mice were pro-
vided by Neurotune, Switzerland, and bred at the Research
Institute of the McGill University Health Centre vivarium.
All of the mice were maintained in a heterozygous state
and were backcrossed with wild-type C57BL/6 mice. In all
experiments, 8-month-old mice were used to study the
impact of sporadic denervation and the fidelity of reinner-
vation in young adult muscle. On the day of the experi-
ment, the animals were sacrificed with CO2 asphyxiation
followed by cervical dislocation. The right soleus and
gastrocnemius muscles were dissected free of adipose and
connective tissue and weighed, and a portion of each was
mounted in tragacanth gum and frozen in isopentane pre-
cooled in liquid nitrogen. The remaining portion of each
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muscle was frozen in liquid nitrogen for mRNA and
miRNA (gastrocnemius muscle only in Sarco mouse) ana-
lyses. All experimental procedures with mice were con-
ducted with approval from the Animal Care Committee at
McGill University Health Centre.
Muscle sectioning
Ten-micrometer-thick cross-sections were cut using a
Leica CM-3050-S cryostat (−20 °C) and mounted onto
glass slides. The sections were left to air-dry for 2 h be-
fore being stored at −80 °C until use. Prior to labeling
protocols (see below), the sections were defrosted in
slide boxes for 30 min and allowed to air dry.
Fiber type, size, and proportion assessments
Muscle cross-sections were immunolabeled for myosin
heavy chains (MHCs) I, IIa, IIx, and IIb by a previously
described method [24]. The sections were rehydrated
with PBS (pH 7.2). These sections were blocked using
goat serum (10 % in PBS) and incubated for 1 h at room
temperature with the following primary antibody solu-
tion (unless otherwise stated, from the Developmental
Studies Hybridoma Bank, Iowa, USA): mouse IgG2b
monoclonal anti-MHC type I (BA-F8, 1:25), mouse IgG1
monoclonal anti-MHC type IIa (SC-71, 1:200), mouse
IgM monoclonal anti-MHC type II× (6H1, 1:25), mouse
IgM monoclonal anti-MHC type IIb (BF-F3, 1:200), and
a rabbit IgG polyclonal anti-laminin (ThermoFisher Sci-
entific). The muscle sections were then washed three
times in PBS before being incubated for 1 h at room
temperature with the following secondary antibodies (all
obtained from ThermoFisher Scientific): Alexa Fluor 350
IgG2b (y2b) goat anti-mouse (A-21140, 1:500), Alexa
Fluor 594 IgG1 (y1) goat anti-mouse (A-21125, 1:100),
Alexa Fluor 488 IgM goat anti-mouse (A-21042, 1:500), and
Alexa Fluor 488 IgG goat anti-rabbit (A-11008, 1:500) di-
luted in blocking solution. Due to the presence of four
MHC isoforms in rodent muscle, labeling was performed on
two serial sections (section 1: three MHC antibodies + lam-
inin, section 2: one MHC antibody + laminin). Muscle
cross-sections were then washed three times in PBS, and
coverslips were applied to slides using Prolong Gold
(ThermoFisher Scientific; P36930) as mounting medium.
The slides were imaged with a Zeiss fluorescence micro-
scope (Axio Imager, Zeiss, Oberkochen, Germany). Frames
for analysis were systematically sampled across each muscle
section. The frequency of very small fibers was assessed as
an index of the degree of persistent denervation in both
aging rat and Sarco mice, based upon previous data from
our group showing that fibers of this size in VO rat gastro-
cnemius muscle exhibit >90 % positive labeling for a marker
of denervation, the sodium channel isoform Nav1.5 [3]. Spe-
cifically, we used the fiber size corresponding to the first per-
centile in YA (for rat) or WT (for mice) animals to define
very small fiber size. The first percentile was determined by
calculating the size distribution of all fibers for all animals in
either YA rats or WT mice. In VO rat VL muscle, this cor-
responded to fibers with a size of ≤1000 μm2, whereas in
Sarco mouse, this corresponded to fibers with a size of
650 μm2 in gastrocnemius muscle and ≤575 μm2 in soleus
muscle.
Neuromuscular junction labeling
We first labeled sections to identify levels of activated
MuSK based upon phospho-MuSK staining intensity.
Tissue cross-sections of rat VL and mouse gastrocne-
mius muscle were rehydrated with PBS and then fixed in
2 % paraformaldehyde containing Phosphatase Inhibitor
Cocktail tablet for 10 min at room temperature and then
washed (4 × 5 min PBS, 1× PBS) before being incubated
in permeabilization solution (0.2 % Tween 20 in PBS) at
room temperature for 10 min. The sections were washed
again and incubated in blocking solution (10 % NGS) for
60 min. Incubation with anti-MuSK (phospho Y755)
antibody (1:250 in blocking buffer; Rabbit polyclonal,
Abcam; ab192583) was performed overnight at 4 °C in a
humidified chamber. The slides were washed and then
incubated with AF594 IgG goat anti-rabbit (Thermo-
Fisher Scientific, A11037; 1:100 in blocking buffer) anti-
body for 1 h at room temperature. The sections were
washed a final time and then mounted with ProLong
Gold Antifade Mountant (ThermoFischer Scientific). Im-
ages were captured on an Axio Imager M2 (Zeiss)
microscope using ×40 objective.
We next examined the downstream impact of alter-
ations in MuSK activation by examining muscle endplate
levels of the AChR tethering protein, rapsyn, and AChR
intensity levels. Tissue cross-sections of rat VL and mouse
gastrocnemius muscle were fixed in acetone for 15 min at
4 °C then washed (2 × 5 min PBST, 1× PBS) before being
incubated in permeabilization solution (0.1 % Triton in
PBS) at room temperature for 15 min. The sections were
washed again and incubated in blocking solution (1 %
NGS 5 % BSA) for 30 min. Incubation with α-
bungarotoxin 488 conjugate (ThermoFisher Scientific;
B13422) and rapsyn (mouse monoclonal, Abcam;
Ab11423) was performed at room temperature for 2 h in
a humidified chamber, where all dilutions were made up
in blocking solution. The slides were washed, and AF350
IgG1 goat anti-mouse (ThermoFisher Scientific 1:100) was
applied for 1 h at room temperature. The sections were
washed a final time and then mounted with ProLong Gold
Antifade Mountant (ThermoFischer Scientific). Images
were captured on an Axio Imager M2 (Zeiss) and then de-
convoluted on Autoquant X3 using the “blind deconvolu-
tion” setting and image parameters provided by the Axio
imager M2 metadata. Analysis of NMJ labeling was
performed using ImageJ (National Institutes of Health,
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Bethesda), with NMJs being traced semi-automatically
and the investigator blinded to the group status of the
animal.
Gene expression
Total RNA was extracted from YA and VO rat vastus latera-
lis muscle samples using the RNeasy Lipid Tissue Mini Kit
(Qiagen; 74804). Quantification and purity of total RNA was
assessed with a nanodrop by examining the A260/A280 ab-
sorption ratio. RNA (1 μg) was reverse transcribed to cDNA
using qScript™ cDNA Synthesis Kit (Quanta biosciences;
95047-025), according to the manufacturer’s instructions.
Real-time PCR was performed using a StepOnePlus™ Real-
Time PCR system (ThermoFisher Scientific) to quantify the
different denervation-related genes (Musk, AChRα, AChRγ,
cPLA2, NCAM, and RUNX1) (Additional file 1: Table S1)
and neurotrophin-related genes (BDNF, NGF, GDNF, CNTF,
p75NTR, NTRK1, NTRK2, NTRK3, GFRA1, CNTFR)
(Additional file 1: Table S2). TATA box binding protein
(TBP) (endogenous control) was obtained from RealTime-
Primers.com. Primers were designed with a freely available
software, Primer 3 plus. Power SYBR® Green PCR Master
Mix (ThermoFisher Scientific; 4367659) was used to quan-
tify the mRNA. The thermal profile was 95 °C for 10 min
and 40 cycles of 95 °C for 15 s and 55–60 °C for 60 s. All
real-time PCR experiments were performed in triplicate,
and melt curve analysis for each PCR experiment was per-
formed to assess primer dimer formation or contamination.
The comparative threshold cycle (CT) method was used to
calculate fold changes in expression. Relative foldchanges in
gene expression were presented as 2−ΔΔCTand normalized
to YA (F344BN rats) or WT (Sarco mice) values.
MicroRNA analysis
Freely available target scan software (www.targetsca-
n.org) was used for predicting microRNAs targeting
BDNF, NT3, and NGF genes. Subsequently, we used the
software miRBase (www.mirbase.org) to obtain the se-
quence of the different miRNAs predicted to target these
neurotrophin genes. Total RNA was extracted from both
YA and VO rat VL muscle using mirVana™ miRNA Iso-
lation Kit, with phenol (Thermo Fisher Scientific Inc;
AM1560), according to the manufacturers’ protocols.
MiRNAs were detected using an NCodeTM miRNA
qRT-PCR Kit (ThermoFisher Scientific; 45-6612) and
real-time PCR (StepOnePlus™ Real-Time PCR system,
Thermal Cycling Block; ThermoFisher Scientific) with
specific primers (Additional file 1: Table S3), Platinum®
SYBR® Green qPCR SuperMix-UDG (ThermoFisher
Scientific; 11733-038). All experiments were performed in
triplicate. Relative miRNA expression was determined using
the CT method, where CT values of individual miRNA data
were normalized to CT values of miR-191a-5p. (Fig. 5)
Statistical analysis
GRAPHPAD PRISM (GraphPad Software, Inc. La Jolla,
CA, USA) software was used for statistical analysis. All
statistical analyses involved an unpaired two sided T test
when comparing two groups. Fiber type distribution was
analyzed by two-way ANOVA (fiber type x group), with
a Sidak’s post hoc test. The outliers were detected by
using GraphPad prism Grubbs’ test. P < 0.05 was consid-
ered as statistically significant.
Additional file
Additional file 1: Table S1. DNA sequences and primers for qPCR
analyses of neurotrophins and neurotrophin receptors in rat skeletal
muscle. Table S2. DNA sequences of primers used for qPCR analyses of
neurotrophins and neurotrophin receptors in mouse muscle. Table S3.
microRNA sequences of primers used to perform QPCR experiments to
detect miR levels in rat vastus lateralis and mouse gastrocnemius muscle.
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